- Home
- TRST vs BBNX Comparison
TRST vs BBNX Comparison
Compare TRST & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- BBNX
- Stock Information
- Founded
- TRST 1902
- BBNX 2015
- Country
- TRST United States
- BBNX United States
- Employees
- TRST N/A
- BBNX N/A
- Industry
- TRST Major Banks
- BBNX Medical/Dental Instruments
- Sector
- TRST Finance
- BBNX Health Care
- Exchange
- TRST Nasdaq
- BBNX Nasdaq
- Market Cap
- TRST 755.5M
- BBNX 740.7M
- IPO Year
- TRST N/A
- BBNX 2025
- Fundamental
- Price
- TRST $39.16
- BBNX $25.31
- Analyst Decision
- TRST
- BBNX Strong Buy
- Analyst Count
- TRST 0
- BBNX 10
- Target Price
- TRST N/A
- BBNX $24.40
- AVG Volume (30 Days)
- TRST 135.2K
- BBNX 682.8K
- Earning Date
- TRST 10-20-2025
- BBNX 11-06-2025
- Dividend Yield
- TRST 3.64%
- BBNX N/A
- EPS Growth
- TRST 8.63
- BBNX N/A
- EPS
- TRST 2.81
- BBNX N/A
- Revenue
- TRST $177,008,000.00
- BBNX $69,830,000.00
- Revenue This Year
- TRST $13.13
- BBNX $42.80
- Revenue Next Year
- TRST N/A
- BBNX $34.58
- P/E Ratio
- TRST $14.08
- BBNX N/A
- Revenue Growth
- TRST 2.80
- BBNX 38911.17
- 52 Week Low
- TRST $27.18
- BBNX $8.89
- 52 Week High
- TRST $40.96
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- TRST 59.97
- BBNX 76.39
- Support Level
- TRST $38.85
- BBNX $18.12
- Resistance Level
- TRST $40.19
- BBNX $26.66
- Average True Range (ATR)
- TRST 0.91
- BBNX 1.38
- MACD
- TRST -0.15
- BBNX 0.64
- Stochastic Oscillator
- TRST 40.59
- BBNX 85.37
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.